Sanam Nami

743 total citations
31 papers, 564 citations indexed

About

Sanam Nami is a scholar working on Epidemiology, Infectious Diseases and Microbiology. According to data from OpenAlex, Sanam Nami has authored 31 papers receiving a total of 564 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 14 papers in Infectious Diseases and 7 papers in Microbiology. Recurrent topics in Sanam Nami's work include Antifungal resistance and susceptibility (13 papers), Fungal Infections and Studies (8 papers) and Reproductive tract infections research (4 papers). Sanam Nami is often cited by papers focused on Antifungal resistance and susceptibility (13 papers), Fungal Infections and Studies (8 papers) and Reproductive tract infections research (4 papers). Sanam Nami collaborates with scholars based in Iran, United States and United Kingdom. Sanam Nami's co-authors include Hamid Morovati, Leili Aghebati‐Maleki, Ali Aghebati‐Maleki, Hamed Mirzaei, Rasoul Mohammadi, Adel Spotin, Behzad Baradaran, Mahmoud Mahami‐Oskouei, Ehsan Ahmadpour and Hamid Badali and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of Cellular Physiology.

In The Last Decade

Sanam Nami

29 papers receiving 552 citations

Peers

Sanam Nami
Avery Goodwin United States
Sanam Nami
Citations per year, relative to Sanam Nami Sanam Nami (= 1×) peers Avery Goodwin

Countries citing papers authored by Sanam Nami

Since Specialization
Citations

This map shows the geographic impact of Sanam Nami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanam Nami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanam Nami more than expected).

Fields of papers citing papers by Sanam Nami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sanam Nami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanam Nami. The network helps show where Sanam Nami may publish in the future.

Co-authorship network of co-authors of Sanam Nami

This figure shows the co-authorship network connecting the top 25 collaborators of Sanam Nami. A scholar is included among the top collaborators of Sanam Nami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sanam Nami. Sanam Nami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nami, Sanam, et al.. (2025). Comparing the effects of Mycozin and Clotrimazole 1% creams on vaginal candidiasis: a triple-blinded randomized controlled trial. Scientific Reports. 15(1). 2356–2356. 1 indexed citations
2.
Hashemi, Seyed Jamal, et al.. (2024). Distribution of fungal agents in the respiratory system of patients with underlying lung diseases; molecular identification and antifungal susceptibility profiles. Iranian Journal of Microbiology. 16(6). 792–802. 1 indexed citations
3.
Aghebati‐Maleki, Leili, Sanam Nami, Amir Baghbanzadeh, et al.. (2023). Induction of TLR5, IRAK1, and NF-κB expression by Trichomonas vaginalis in cervical cancer cell (HeLa) and normal human vaginal epithelial cell (HVECs) lines. The Journal of Infection in Developing Countries. 17(8). 1160–1167.
4.
Spotin, Adel, Hamid Morovati, Leili Aghebati‐Maleki, et al.. (2023). Molecular diagnosis, phylogenetic analysis, and antifungal susceptibility profiles of Candida species isolated from neutropenic oncological patients. BMC Infectious Diseases. 23(1). 765–765. 2 indexed citations
5.
Hamishehkar, Hamed, Behzad Baradaran, Siamak Sandoghchian Shotorbani, et al.. (2021). Antifungal Effects of Voriconazole-Loaded Nano-Liposome on Fluconazole - Resistant Clinical Isolates of Candida albicans , Biological Activity and ERG11, CDR1, and CDR2 Gene Expression. Assay and Drug Development Technologies. 19(7). 453–462. 12 indexed citations
6.
Montazeri, Mahbobeh, Sanam Nami, Hamed Hamishehkar, et al.. (2021). Nanoliposomes increases Anti-Trichomonas vaginalis and apoptotic activities of metronidazole. Acta Tropica. 224. 106156–106156. 3 indexed citations
7.
Hamishehkar, Hamed, Behzad Baradaran, Maryam Mohammadi, et al.. (2020). An appraisal of antifungal impacts of nano-liposome containing voriconazole on voriconazole-resistant Aspergillus flavus isolates as a groundbreaking drug delivery system. SHILAP Revista de lepidopterología. 5(1). 90–100. 9 indexed citations
8.
Ahmadpour, Ehsan, Lihua Xiao, Mehdi Zarean, et al.. (2020). Cryptosporidiosis in HIV-positive patients and related risk factors: A systematic review and meta-analysis. Parasite. 27. 27–27. 49 indexed citations
9.
Nami, Sanam, Ali Aghebati‐Maleki, Zohreh Babaloo, & Leili Aghebati‐Maleki. (2020). Effects of fasting on the immune system function and its positive effects on the chemotherapy of various types of cancer. Koomesh Journal. 22(3). 404–410.
10.
Pakshir, Keyvan, et al.. (2019). Interactions between immune response to fungal infection and microRNAs: The pioneer tuners. Mycoses. 63(1). 4–20. 14 indexed citations
11.
Spotin, Adel, Mahmoud Mahami‐Oskouei, & Sanam Nami. (2019). Assessment of the global paradigms of genetic variability in Strongyloides stercoralis infrapopulations determined by mitochondrial DNA sequences. Comparative Immunology Microbiology and Infectious Diseases. 67. 101354–101354. 6 indexed citations
12.
Ahmadpour, Ehsan, Adel Spotin, Roghayeh Norouzi, et al.. (2019). Nanostructured lipid carriers of ivermectin as a novel drug delivery system in hydatidosis. Parasites & Vectors. 12(1). 469–469. 30 indexed citations
13.
Nami, Sanam, Ali Aghebati‐Maleki, Hamid Morovati, & Leili Aghebati‐Maleki. (2018). Current antifungal drugs and immunotherapeutic approaches as promising strategies to treatment of fungal diseases. Biomedicine & Pharmacotherapy. 110. 857–868. 113 indexed citations
14.
Dehghan, Parvin, et al.. (2018). TLR-2, IL-10 and IL-17-mediated immunity in experimental chemotherapy murine model of systemic candidiasis; cyclophosphamides' impact and roles. Microbial Pathogenesis. 119. 183–192. 21 indexed citations
15.
Nami, Sanam, et al.. (2018). Fungal vaccines, mechanism of actions and immunology: A comprehensive review. Biomedicine & Pharmacotherapy. 109. 333–344. 108 indexed citations
16.
Nami, Sanam, Behzad Baradaran, Behzad Mansoori, et al.. (2017). The Utilization of RNA Silencing Technology to Mitigate the Voriconazole Resistance of Aspergillus Flavus; Lipofectamine-Based Delivery. Advanced Pharmaceutical Bulletin. 7(1). 53–59. 14 indexed citations
17.
Mohammadi, Ali, Behzad Mansoori, Mahyar Aghapour, et al.. (2016). The Urtica dioica extract enhances sensitivity of paclitaxel drug to MDA-MB-468 breast cancer cells. Biomedicine & Pharmacotherapy. 83. 835–842. 33 indexed citations
18.
Falahati, Mehraban, et al.. (2012). REPORT OF 34 CASES OF SAPROPHYTIC FUNGI ISOLATED FROM DYSTROPHIC NAILS OF PATIENTS REFERRED TO RAZI HOSPITAL (2010 - 2011). Razi Journal of Medical Sciences. 18(92). 8–14. 2 indexed citations
19.
Nami, Sanam, et al.. (2012). Comparision of antifungal effect of fluconazole alone and in combination with nanosilver particles against candida species isolated from chronic candidal vulvovaginitis. Razi Journal of Medical Sciences. 18(93). 8–14. 6 indexed citations
20.
Falahati, Mehraban, et al.. (2012). INVESTIGATION OF PREVALENCE OF ONYCHOMYCOSIS DUE TO YEAST FUNGI IN DYSTROPHIC NAILS OF PATIENTS WHO REFERRED TO RAZI HOSPITAL (2010 - 2011). 19(96). 26–33. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026